Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.
| dc.contributor.author | Alexopoulos, Anastasia-Stefania | |
| dc.contributor.author | Crowley, Matthew J | |
| dc.contributor.author | Wang, Ying | |
| dc.contributor.author | Moylan, Cynthia A | |
| dc.contributor.author | Guy, Cynthia D | |
| dc.contributor.author | Henao, Ricardo | |
| dc.contributor.author | Piercy, Dawn L | |
| dc.contributor.author | Seymour, Keri A | |
| dc.contributor.author | Sudan, Ranjan | |
| dc.contributor.author | Portenier, Dana D | |
| dc.contributor.author | Diehl, Anna Mae | |
| dc.contributor.author | Coviello, Andrea D | |
| dc.contributor.author | Abdelmalek, Manal F | |
| dc.date.accessioned | 2021-04-01T19:00:38Z | |
| dc.date.available | 2021-04-01T19:00:38Z | |
| dc.date.issued | 2021-03-16 | |
| dc.date.updated | 2021-04-01T19:00:37Z | |
| dc.description.abstract | Background and aimsWhether glycemic control, as opposed to diabetes status, is associated with the severity of nonalcoholic fatty liver disease (NAFLD) is unknown. We aimed to evaluate whether degree of glycemic control in the years preceding liver biopsy predicts the histologic severity of nonalcoholic steatohepatitis (NASH).Methods & resultsUsing the Duke NAFLD Clinical Database we examined patients with biopsy-proven NAFLD/NASH (n=713) and the association of liver injury with glycemic control as measured by hemoglobin A1c (HbA1c). The study cohort was predominantly female (59%), Caucasian (84%) with median (IQR) age of 50 (42, 58) years; 49% had diabetes (n=348). Generalized linear regression models adjusted for age, sex, race, diabetes, body mass index, and hyperlipidemia were used to assess the association between mean HbA1c over the year preceding liver biopsy and severity of histologic features of NAFLD/NASH. Histologic features were graded and staged according to NASH Clinical Research Network system. Group-based trajectory analysis was used to examine patients with ≥3 HbA1c (n=298) measures over 5 years preceding clinically indicated liver biopsy. Higher mean HbA1c was associated with higher grade of steatosis and ballooned hepatocytes, but not lobular inflammation. Every 1% increase in mean HbA1c was associated with 15% higher odds of increased fibrosis stage (OR 1.15, 95% CI 1.01, 1.31). As compared with good glycemic control, moderate control was significantly associated with increased severity of ballooned hepatocytes (OR 1.74, 95% CI 1.01, 3.01, p=0.048) and hepatic fibrosis (OR 4.59, 95% CI 2.33, 9.06, p<0.01).ConclusionsGlycemic control predicts severity of ballooned hepatocytes and hepatic fibrosis in NAFLD/NASH, and thus optimizing glycemic control may be a means of modifying risk of NASH-related fibrosis progression. | |
| dc.identifier.issn | 0270-9139 | |
| dc.identifier.issn | 1527-3350 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
| dc.relation.ispartof | Hepatology (Baltimore, Md.) | |
| dc.relation.isversionof | 10.1002/hep.31806 | |
| dc.subject | biopsy | |
| dc.subject | diabetes | |
| dc.subject | hemoglobin A1c | |
| dc.subject | histology | |
| dc.subject | nonalcoholic steatohepatitis | |
| dc.title | Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Crowley, Matthew J|0000-0002-6205-4536 | |
| duke.contributor.orcid | Moylan, Cynthia A|0000-0001-8454-7086 | |
| duke.contributor.orcid | Henao, Ricardo|0000-0003-4980-845X | |
| duke.contributor.orcid | Seymour, Keri A|0000-0002-2735-0786 | |
| duke.contributor.orcid | Sudan, Ranjan|0000-0002-4231-242X | |
| duke.contributor.orcid | Abdelmalek, Manal F|0000-0002-5001-8618 | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Surgery, Metabolic and Weight Loss Surgery | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Surgery | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke Clinical Research Institute | |
| pubs.organisational-group | Medicine, Endocrinology, Metabolism, and Nutrition | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.publication-status | Published |
Files
Original bundle
- Name:
- hep.31806.pdf
- Size:
- 2.01 MB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version